Tamara Božina

447 total citations
34 papers, 312 citations indexed

About

Tamara Božina is a scholar working on Oncology, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Tamara Božina has authored 34 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pharmacology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Tamara Božina's work include Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Tamara Božina is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (8 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Tamara Božina collaborates with scholars based in Croatia, Slovenia and United Kingdom. Tamara Božina's co-authors include Nada Božina, Jadranka Sertić, Jasna Lovrić, Mila Lovrić, Lana Ganoci, Martina Rojnić Kuzman, Zdravka Poljaković, Sanja Hajnšek, Željko Reiner and Vladimir Trkulja and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and Medicine.

In The Last Decade

Tamara Božina

31 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tamara Božina Croatia 12 75 74 67 65 57 34 312
Inga Peter United States 12 49 0.7× 73 1.0× 31 0.5× 33 0.5× 58 1.0× 17 374
Yin Hu China 9 37 0.5× 50 0.7× 62 0.9× 39 0.6× 46 0.8× 32 274
Bhaskar Rege United States 11 35 0.5× 56 0.8× 75 1.1× 34 0.5× 40 0.7× 31 325
Risa Takayanagi Japan 12 51 0.7× 31 0.4× 38 0.6× 34 0.5× 52 0.9× 57 362
Muradiye Nacak Türkiye 13 203 2.7× 81 1.1× 36 0.5× 103 1.6× 130 2.3× 29 598
Ali R. Saadatmand Germany 10 68 0.9× 184 2.5× 48 0.7× 245 3.8× 103 1.8× 12 501
Carmen Belmonte Spain 14 188 2.5× 111 1.5× 118 1.8× 84 1.3× 47 0.8× 21 455
C. Le Grazie Italy 11 48 0.6× 35 0.5× 46 0.7× 41 0.6× 85 1.5× 21 545
Lana Ganoci Croatia 10 77 1.0× 48 0.6× 37 0.6× 70 1.1× 39 0.7× 31 260
Ben Burkley United States 8 144 1.9× 55 0.7× 15 0.2× 80 1.2× 89 1.6× 9 400

Countries citing papers authored by Tamara Božina

Since Specialization
Citations

This map shows the geographic impact of Tamara Božina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamara Božina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamara Božina more than expected).

Fields of papers citing papers by Tamara Božina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamara Božina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamara Božina. The network helps show where Tamara Božina may publish in the future.

Co-authorship network of co-authors of Tamara Božina

This figure shows the co-authorship network connecting the top 25 collaborators of Tamara Božina. A scholar is included among the top collaborators of Tamara Božina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tamara Božina. Tamara Božina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Belančić, Andrej, et al.. (2024). Metabolic Syndrome Drug Therapy: The Potential Interplay of Pharmacogenetics and Pharmacokinetic Interactions in Clinical Practice: A Narrative Review. SHILAP Revista de lepidopterología. 5(4). 406–429. 6 indexed citations
4.
Ganoci, Lana, Vladimir Trkulja, Nada Božina, et al.. (2024). Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?. Genes. 15(5). 607–607. 1 indexed citations
5.
Trkulja, Vladimir, et al.. (2024). Common P-glycoprotein (ABCB1) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events. Biochemia Medica. 34(2). 263–278. 2 indexed citations
6.
Kirhmajer, Majda Vrkić, et al.. (2023). Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series. SHILAP Revista de lepidopterología. 11(1). 29–29. 4 indexed citations
7.
8.
Rašić, Dubravka, Suzana Žunec, Tamara Božina, et al.. (2023). The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats. Archives of Industrial Hygiene and Toxicology. 74(1). 34–41. 1 indexed citations
9.
Božina, Nada, et al.. (2021). Drug-drug-gene interactions as mediators of adverse drug reactions to diclofenac and statins: a case report and literature review. Archives of Industrial Hygiene and Toxicology. 72(2). 114–128. 7 indexed citations
10.
Trkulja, Vladimir, et al.. (2021). Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case–control study. European Journal of Clinical Pharmacology. 78(2). 227–236. 12 indexed citations
11.
Kuzman, Martina Rojnić, et al.. (2019). Association of CNR1 genotypes with changes in neurocognitive performance after eighteen-month treatment in patients with first-episode psychosis. European Psychiatry. 61. 88–96. 11 indexed citations
12.
Božina, Nada, et al.. (2019). Pharmacogenetics and the Treatment of Epilepsy: What Do We Know?. Pharmacogenomics. 20(15). 1093–1101. 10 indexed citations
13.
Ganoci, Lana, et al.. (2017). Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9 , CYP2C19 , CYP2D6 , CYP3A4 , and CYP3A5 in the Croatian population. Drug Metabolism and Personalized Therapy. 32(1). 11–21. 26 indexed citations
14.
15.
Kao, Amy, Martina Rojnić Kuzman, Arun K. Tiwari, et al.. (2014). Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances. Journal of Psychiatric Research. 54. 36–42. 23 indexed citations
16.
Božina, Tamara, et al.. (2013). Interaction of Genetic Risk Factors Confers Increased Risk for Metabolic Syndrome: The Role of Peroxisome Proliferator-Activated Receptor γ. Genetic Testing and Molecular Biomarkers. 18(1). 32–40. 6 indexed citations
17.
Božina, Tamara, et al.. (2013). Effects of lipoprotein lipase and peroxisome proliferator-activated receptor-gamma gene variants on metabolic syndrome traits.. PubMed. 37(3). 801–8. 7 indexed citations
18.
Lovrić, Mila, et al.. (2012). Association Between Lamotrigine Concentrations and ABCB1 Polymorphisms in Patients With Epilepsy. Therapeutic Drug Monitoring. 34(5). 518–525. 40 indexed citations
19.
Sertić, Jadranka, Boško Skorić, Jasna Lovrić, Tamara Božina, & Željko Reiner. (2010). [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].. PubMed. 64(4). 237–45. 11 indexed citations
20.
Sertić, Jadranka, et al.. (2009). Variants of ESR1, APOE, LPL and IL-6 loci in young healthy subjects: association with lipid status and obesity. BMC Research Notes. 2(1). 203–203. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inga Peter Breakdown of academic impact, for papers by Yin Hu Breakdown of academic impact, for papers by Bhaskar Rege Breakdown of academic impact, for papers by Risa Takayanagi Breakdown of academic impact, for papers by Muradiye Nacak Breakdown of academic impact, for papers by Ali R. Saadatmand Breakdown of academic impact, for papers by Carmen Belmonte Breakdown of academic impact, for papers by C. Le Grazie Breakdown of academic impact, for papers by Lana Ganoci Breakdown of academic impact, for papers by Ben Burkley
Rankless by CCL
2026